Company Filing History:
Years Active: 2015
Title: The Innovations of Daniel Schlatter
Introduction
Daniel Schlatter is an accomplished inventor based in Ettingen, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic compounds. His innovative work has led to the creation of a patent that addresses important medical applications.
Latest Patents
Daniel Schlatter holds a patent for "Chymase binding compounds and medical uses thereof." This invention relates to a polypeptide that binds to chymase (EC 3.4.21.39). The polypeptide comprises an amino acid sequence that includes various specified amino acids, which can be modified to enhance its binding properties. This patent represents a significant advancement in the development of targeted therapies.
Career Highlights
Daniel Schlatter is currently employed at Covagen AG, a company known for its innovative approaches in the field of biopharmaceuticals. His work at Covagen AG has allowed him to focus on the development of novel therapeutic agents that can improve patient outcomes. His expertise in biochemistry and molecular biology has been instrumental in driving forward the company's research initiatives.
Collaborations
Daniel has collaborated with notable colleagues, including Simon Brack and Sarah Batey. These collaborations have fostered a productive research environment, leading to advancements in their respective fields.
Conclusion
Daniel Schlatter's contributions to the field of biochemistry through his innovative patent and work at Covagen AG highlight his role as a leading inventor. His dedication to developing new therapeutic solutions continues to impact the medical community positively.